Clinical Trial Update: BM-MNCs for Lower Extremity Compartment Syndrome Injury [Phase 1]

View source ↗

Summary

Phase 1 clinical trial by Oregon Health and Science University evaluating autologous bone marrow mononuclear cells for traumatic compartment syndrome of the low…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compartment Syndrome

Drugs mentioned

• Bone marrow-derived mononuclear cells (BM-MNCs)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Compartment Syndrome Traumatic Lower Extremity | Phase 1 | Status: ACTIVE_NOT_RECRUITING